Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice

M Ząbczyk, RAS Ariëns, A Undas - Cardiovascular research, 2023 - academic.oup.com
Fibrinogen conversion into insoluble fibrin and the formation of a stable clot is the final step
of the coagulation cascade. Fibrin clot porosity and its susceptibility to plasmin-mediated …

[HTML][HTML] Targeted treatment against lipoprotein (a): the coming breakthrough in lipid lowering therapy

B Sosnowska, S Surma, M Banach - Pharmaceuticals, 2022 - mdpi.com
Atherosclerotic cardiovascular diseases (ASCVD) are a very important cause of premature
death. The most important risk factor for ASCVD is lipid disorders. The incidence of lipid …

A two-pronged detection of atherosclerosis with a dual-channel fluorescent probe for viscosity and hypochlorous acid

Z Wang, S Wang, B Wang, J Shen, L Zhao, F Yu… - Chemical Engineering …, 2023 - Elsevier
The precise detection of atherosclerosis has been a research hot point since its importance
in the diagnosis of cardiovascular diseases. Here we synthesized a near-infrared …

[HTML][HTML] Unexpected relationships: Periodontal diseases: atherosclerosis–plaque destabilization? From the teeth to a coronary event

MR Czerniuk, S Surma, M Romańczyk, JM Nowak… - Biology, 2022 - mdpi.com
Simple Summary Periodontal disease and atherosclerotic cardiovascular disease are very
common around the world. Coronary artery disease is the leading cause of death. The main …

[HTML][HTML] The impact of periodontitis on vascular endothelial dysfunction

Q Li, X Ouyang, J Lin - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
Periodontitis, an oral inflammatory disease, originates from periodontal microbiota dysbiosis
which is associated with the dysregulation of host immunoinflammatory response. This …

[HTML][HTML] Vulnerable atherosclerotic plaque: is there a molecular signature?

RM Chiorescu, M Mocan, AI Inceu, AP Buda… - International Journal of …, 2022 - mdpi.com
Atherosclerosis and its clinical manifestations, coronary and cerebral artery diseases, are
the most common cause of death worldwide. The main pathophysiological mechanism for …

A self-driven, microfluidic, integrated-circuit biosensing chip for detecting four cardiovascular disease biomarkers

PR Li, SK Boilla, CH Wang, PC Lin, CN Kuo… - Biosensors and …, 2024 - Elsevier
Cardiovascular diseases (CVDs) claimed the lives of nearly 21 million people worldwide in
2021, accounting for 30% of global deaths. However, one in five CVD patients is unaware …

[HTML][HTML] Focus on the most common paucisymptomatic vasculopathic population, from diagnosis to secondary prevention of complications

E Martelli, I Enea, M Zamboni, M Federici, UM Bracale… - Diagnostics, 2023 - mdpi.com
Middle-aged adults can start to be affected by some arterial diseases (ADs), such as
abdominal aortic or popliteal artery aneurysms, lower extremity arterial disease, internal …

NAFLD: An emerging causal factor for cardiovascular disease

M Li, H Wang, X Zhang, J Cai, H Li - Physiology, 2023 - journals.physiology.org
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease
worldwide that poses a significant threat to human health. Cardiovascular disease (CVD) is …

[HTML][HTML] Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases

T Gou, M Hu, M Xu, Y Chen, R Chen, T Zhou… - Journal of …, 2023 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) frequently results in sudden death and
poses a serious threat to public health worldwide. The drugs approved for the prevention …